Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Zemuron Articles

Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders

9 February 2009

APP debuts generic Zemuron in USA

26 January 2009

Sugammdex filed with Japan's MHLW

28 January 2008

S-P's sugammadex NDA gets priority status

14 January 2008

Sugammadex MAA accepted by EMEA

30 July 2007

Japanese regulator gives nod to three new drugs

21 May 2007

Akzo Nobel's 2006 net income increases 20%

26 February 2007

Akzo's Organon expects one NDA filing a year from its R&D pipeline

3 April 2006

New Chemical Entities Round-Up For 1994

6 February 1995

Fast FDA Approvals Of User-Fee NMEs In 1994

16 January 1995

ZEMURON LAUNCHED IN USA SOON

28 March 1994

FDA REPORT ON ZEMURON

25 October 1993

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS